The Company Town That Runs Your Doctor's Mind

Our medical research system almost exclusively funds what can be patented — leaving hundreds of affordable, potentially life-saving treatments permanently unstudied, untaught, and unavailable to the patients who need them most.

I know this personally.

I lost my father as a child, then my sisters, then my only son — different diseases, different decades, same outcome. Modern medicine had no answers for any of them. That grief became my mission. And the more I looked, the more I understood that the problem wasn't bad doctors.

It was a broken map.

Socrates spent his life exposing an uncomfortable truth — that the most dangerous people aren't the ignorant ones. They're the confident ones. The ones who've stopped asking questions because they already know the answer.

We never fixed that problem.

We just built better institutions around it.

---

Consider the Company Town.

In the classic company town, one employer owns everything — the houses, the stores, the newspaper, the school. Workers don't just work for the company. They think like the company. Their neighbors work there. Their pastor's salary depends on it. Dissent doesn't get punished. It just never occurs to anyone.

That is modern American medicine.

The NIH hands out $117 million every single day to universities and biotech companies. Under the Bayh-Dole Act of 1980, whatever gets discovered with that public money can be privately patented. The incentive is baked in from day one — don't research what heals people. Research what can be owned.

And so the town runs on patents.

---

Here is what that looks like in practice.

NIH's budget grew from $31 billion in 2016 to nearly $47 billion by 2025. Of that, an estimated $20 to $28 billion went to Alzheimer's research over that decade — ramping from under $1 billion a year to nearly $4 billion annually — the vast majority chasing patentable drug targets. In that same period, NIH spent a negligible fraction researching lithium. A naturally occurring, unpatentable mineral. A landmark 2025 Harvard study published in Nature found that lithium is deficient in the brains of Alzheimer's patients. Lithium orotate, at low doses, reversed memory loss in mice. You cannot patent lithium. So the town ignores it.

Food poisoning kills over 3,000 Americans a year and sends 120,000 to hospitals. Lugol's Iodine — cheap, unpatentable, sitting in your medicine cabinet — can stop it within minutes. NIH has spent nothing researching it. Doctors don't know about it. Because the town never told them.

Less than 1% of NIH funding goes to non-patentable treatments. Vitamins. Minerals. Herbs. Enzymes. Peptides. Amino acids. Probiotics. LED therapy. Saunas. Things that can't be owned, so they don't get studied.

And here is how silence compounds.

The doctor never learned it — because the professor never taught it — because the researcher never studied it — because the grant never funded it. By the time it reaches the patient, the absence is invisible. Nobody withheld anything. The information simply never existed in the room.

That's not conspiracy. That's just how a company town works.

---

The most fascinating part isn't the politicians or the lobbyists.

It's the doctors.

Gladwell wrote about how people in company towns don't feel coerced — they feel normal. A doctor who trained at a university funded by NIH grants, who reads journals funded by pharmaceutical advertising, who practices in a system reimbursed for procedures and prescriptions — that doctor isn't corrupt. They are just a loyal citizen of the town.

Their relatives think the same way. Their patients defer to them. The local news runs pharma ads — the US and New Zealand are the only two countries on earth that allow direct-to-consumer drug advertising. Not to sell drugs. The side effect disclaimers take care of that. The real purpose is influence. To keep mainstream media pumping out hit pieces on integrative medicine — articles dressed up as science, but really just the opinion of a journalist and someone at Harvard. All of it automatically orchestrated to keep the town's flag flying.

Socrates called this mistaking confidence for knowledge.

The emperor called it fashion.

And the doctors — the ones who are smart enough to see it — are quietly falling apart. Nearly half of all American physicians report burnout. Three hundred to four hundred die by suicide every year. Female physicians are dying by suicide at 250 to 400% the rate of women in other professions. More than a third report depression. These are not weak people. These are some of the most disciplined, high-achieving human beings on earth. And they are breaking — inside a system they were trained to trust and never taught to question.

---

Here is the question the town refuses to fund.

We have built a research system extraordinarily good at one thing: testing a single patentable molecule in isolation.

But people don't live single-variable lives.

People facing cancer and chronic disease combine diet, supplements, sleep protocols, stress reduction, environmental changes, and relationship changes — often alongside their prescribed treatment, and often without telling their doctor. They don't tell their oncologist because they already know what would happen. Asking your oncologist about integrative cancer therapy is like asking your plumber to diagnose a complicated electrical problem in your car. It is simply not what they studied. And so the oncologist is kept in the dark. And so the research never gets done. And so the silence continues.

Here is the quiet contradiction at the heart of modern medicine: a compound's path to research funding depends less on its potential benefit, and more on whether it can generate a return. If something can't be patented, it struggles to get studied — at any scale.

That is not a science problem.

That is a funding-priorities problem.

---

And here is what makes it worse.

Randomized controlled trials are extraordinary tools. They are optimized to isolate single variables. But holistic protocols are not single variables. They are systems — diet, sleep, movement, stress, supplementation, environment — interacting across years.

You cannot run a randomized controlled trial on a life.

Which is exactly why the town loves them. The gold standard of evidence happens to be perfectly designed to study the things that can be patented — and perfectly ill-suited to study the things that can't.

This is not an accident.

It is an architecture.

---

So what do we do?

The answer isn't to abandon clinical trials. It is to stop pretending they are the only way to learn.

We need large-scale longitudinal studies that track real people following real protocols over years — diet, supplementation, lifestyle — and measure what actually happens to them. We need real-world evidence registries. We need systems-based research that reflects how human biology actually works: not one variable at a time, but everything at once. We need to study what patients and integrative medicine leaders are already doing — and stop burying it under red tape.

The majority of NIH's budget should be redirected toward exactly this. Not because it is ideologically satisfying. Because patients are already living in this complexity. They are already running the experiment. We are just refusing to watch.

And consider this: AI will inherit whatever blind spots we create today. If our scientific literature focuses almost entirely on patented drugs and ignores everything else, then the algorithms trained on that literature will do the same. The future of medicine depends on what we choose to study now.

---

Three things would change everything.

Ban drug advertising on television. If your product's disclaimer includes the words "may cause death," it has no business running during the evening news.

End pharmaceutical lobbying of elected officials. The conflict of interest isn't subtle.

Redirect NIH funding away from novelty and patents and toward outcomes. Ask one simple question: does it help people? Whether it can be owned should be completely beside the point. Patented medicine should be funded primarily by the drug companies themselves — not by taxpayers who then get charged again at the pharmacy.

The payoff is not abstract.

Lower healthcare costs through real competition. Broader treatment options. Fewer side effects. Fewer preventable deaths. Happier doctors. And a complete map of medicine — not one drawn only by profit.

---

Summary

I lost my father as a child. Then my sisters. Then my only son.

Different diseases. Different decades. Medicine had no answers for any of them.

I used to ask why. Now I understand the architecture.

The greatest medical breakthroughs of the future may not come from what we invent next. They may come from what we finally decide to study.

And in medicine, choosing what to study can mean choosing who gets to live longer, healthier lives.

Florida's new Right to Try legislation gives me hope. NIH, RFK — are you listening?

Let's fund what works. Regardless of who can own it.

The company town only has power as long as nobody notices they're living in one.